264 related articles for article (PubMed ID: 24207129)
1. Towards automated on-line adaptation of 2-Step IMRT plans: QUASIMODO phantom and prostate cancer cases.
Holubyev K; Bratengeier K; Gainey M; Polat B; Flentje M
Radiat Oncol; 2013 Nov; 8():263. PubMed ID: 24207129
[TBL] [Abstract][Full Text] [Related]
2. Probabilistic dose distribution from interfractional motion in carbon ion radiation therapy for prostate cancer shows rectum sparing with moderate target coverage degradation.
Bridges D; Kawamura H; Kanai T
PLoS One; 2018; 13(8):e0203289. PubMed ID: 30169520
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy treatment plans with RapidArc for prostate cancer involving seminal vesicles and lymph nodes.
Yoo S; Wu QJ; Lee WR; Yin FF
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):935-42. PubMed ID: 20044214
[TBL] [Abstract][Full Text] [Related]
4. Prostate and seminal vesicle volume based consideration of prostate cancer patients for treatment with 3D-conformal or intensity-modulated radiation therapy.
Reddy NM; Nori D; Chang H; Lange CS; Ravi A
Med Phys; 2010 Jul; 37(7):3791-801. PubMed ID: 20831087
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric adaptive IMRT driven by fiducial points.
Crijns W; Van Herck H; Defraene G; Van den Bergh L; Slagmolen P; Haustermans K; Maes F; Van den Heuvel F
Med Phys; 2014 Jun; 41(6):061716. PubMed ID: 24877811
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the dosimetric impact of non-exclusion of the rectum from the boost PTV in IMRT treatment plans for prostate cancer patients.
Kassim I; Dirkx ML; Heijmen BJ
Radiother Oncol; 2009 Jul; 92(1):62-7. PubMed ID: 19278745
[TBL] [Abstract][Full Text] [Related]
7. Is ad-hoc plan adaptation based on 2-Step IMRT feasible?
Bratengeier K; Polat B; Gainey M; Grewenig P; Meyer J; Flentje M
Radiother Oncol; 2009 Nov; 93(2):266-72. PubMed ID: 19796833
[TBL] [Abstract][Full Text] [Related]
8. Target miss using PTV-based IMRT compared to robust optimization via coverage probability concept in prostate cancer.
Outaggarts Z; Wegener D; Berger B; Zips D; Paulsen F; Bleif M; Thorwarth D; Alber M; Dohm O; Müller AC
Acta Oncol; 2020 Aug; 59(8):911-917. PubMed ID: 32436467
[No Abstract] [Full Text] [Related]
9. Determination of optimal PTV margin for patients receiving CBCT-guided prostate IMRT: comparative analysis based on CBCT dose calculation with four different margins.
Gill SK; Reddy K; Campbell N; Chen C; Pearson D
J Appl Clin Med Phys; 2015 Nov; 16(6):252–262. PubMed ID: 26699581
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of online/offline image guidance/adaptation approaches for prostate cancer radiation therapy.
Qin A; Sun Y; Liang J; Yan D
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1026-33. PubMed ID: 25832693
[TBL] [Abstract][Full Text] [Related]
11. Real-time adaptive planning method for radiotherapy treatment delivery for prostate cancer patients, based on a library of plans accounting for possible anatomy configuration changes.
Antico M; Prinsen P; Cellini F; Fracassi A; Isola AA; Cobben D; Fontanarosa D
PLoS One; 2019; 14(2):e0213002. PubMed ID: 30818345
[TBL] [Abstract][Full Text] [Related]
12. A quantitative study of IMRT delivery effects in commercial planning systems for the case of oesophagus and prostate tumours.
Seco J; Clark CH; Evans PM; Webb S
Br J Radiol; 2006 May; 79(941):401-8. PubMed ID: 16632620
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric comparison of high-dose-rate brachytherapy and intensity-modulated radiation therapy as a boost to the prostate.
Hermesse J; Biver S; Jansen N; Lenaerts E; Nickers P
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):269-76. PubMed ID: 19775833
[TBL] [Abstract][Full Text] [Related]
14. Passive proton therapy vs. IMRT planning study with focal boost for prostate cancer.
Yeo I; Nookala P; Gordon I; Schulte R; Barnes S; Ghebremedhin A; Wang N; Yang G; Ling T; Bush D; Slater J; Patyal B
Radiat Oncol; 2015 Oct; 10():213. PubMed ID: 26499318
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic IMRT for prostate cancer: dosimetric impact of multileaf collimator leaf width in the treatment of prostate cancer with IMRT.
Wang L; Movsas B; Jacob R; Fourkal E; Chen L; Price R; Feigenberg S; Konski A; Pollack A; Ma C
J Appl Clin Med Phys; 2004; 5(2):29-41. PubMed ID: 15738911
[TBL] [Abstract][Full Text] [Related]
16. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
[TBL] [Abstract][Full Text] [Related]
17. Assessment of different IMRT boost delivery methods on target coverage and normal-tissue sparing.
Dogan N; King S; Emami B; Mohideen N; Mirkovic N; Leybovich LB; Sethi A
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1480-91. PubMed ID: 14630288
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric and radiobiological consequences of computed tomography-guided adaptive strategies for intensity modulated radiation therapy of the prostate.
Battista JJ; Johnson C; Turnbull D; Kempe J; Bzdusek K; Van Dyk J; Bauman G
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):874-80. PubMed ID: 23978708
[TBL] [Abstract][Full Text] [Related]
19. Megavoltage cone beam computed tomography dose and the necessity of reoptimization for imaging dose-integrated intensity-modulated radiotherapy for prostate cancer.
Akino Y; Koizumi M; Sumida I; Takahashi Y; Ogata T; Ota S; Isohashi F; Konishi K; Yoshioka Y
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1715-22. PubMed ID: 21620584
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous integrated boost plan comparison of volumetric-modulated arc therapy and sliding window intensity-modulated radiotherapy for whole pelvis irradiation of locally advanced prostate cancer.
Riou O; Regnault de la Mothe P; Azria D; Aillères N; Dubois JB; Fenoglietto P
J Appl Clin Med Phys; 2013 Jul; 14(4):4094. PubMed ID: 23835376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
